Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To demonstrate the efficacy of adalimumab in the treatment of subjects with Crohn's disease who either initially responded to administration of infliximab but stopped responding or were intolerant to infliximab; to delineate the safety of adalimumab when administered to subjects with Crohn's disease; to assess the pharmacokinetics (PK) of adalimumab following subcutaneous administration.
Inclusion criteria
- Crohn’s Disease